Azenta/$AZTA
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Azenta
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Ticker
$AZTA
Sector
Primary listing
Industry
Life Sciences Tools & Services
Headquarters
Employees
3,000
ISIN
US1143401024
Website
Azenta Metrics
BasicAdvanced
$1.5B
-
-$1.36
1.64
-
Price and volume
Market cap
$1.5B
Beta
1.64
52-week high
$63.58
52-week low
$23.91
Average daily volume
911K
Financial strength
Current ratio
3.22
Quick ratio
2.165
Long term debt to equity
3.156
Total debt to equity
3.156
Profitability
EBITDA (TTM)
28.533
Gross margin (TTM)
41.72%
Net profit margin (TTM)
-9.77%
Operating margin (TTM)
-9.09%
Effective tax rate (TTM)
-3.36%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-1.65%
Return on equity (TTM)
-8.58%
Valuation
Price to revenue (TTM)
2.31
Price to book
0.87
Price to tangible book (TTM)
1.63
Price to free cash flow (TTM)
39.526
Free cash flow yield (TTM)
2.53%
Free cash flow per share (TTM)
81.54%
Growth
Revenue change (TTM)
4.69%
Earnings per share change (TTM)
-46.77%
3-year revenue growth (CAGR)
6.68%
10-year revenue growth (CAGR)
2.92%
3-year earnings per share growth (CAGR)
-64.19%
10-year earnings per share growth (CAGR)
14.13%
What the Analysts think about Azenta
Analyst ratings (Buy, Hold, Sell) for Azenta stock.
Bulls say / Bears say
Azenta's strategic decision to divest B Medical Systems allows the company to focus on higher-growth and higher-margin segments, potentially leading to improved resource allocation and strategic execution. (marketscreener.com)
The company's gross margin increased to 47% from 44% year-over-year, driven by efficiencies in the Sample Management Solutions segment, indicating improved profitability in the core business. (panabee.com)
Azenta's revenue increased by 4% year-over-year, with both Multiomics (+6%) and Sample Management Solutions (+3%) contributing, demonstrating resilient demand for its offerings despite economic uncertainties. (panabee.com)
The company reported an operating loss of $11 million and a net loss of $13 million, widening from the previous year's operating loss of $16 million and net loss of $15.7 million, raising concerns about profitability despite revenue growth. (panabee.com)
Net interest income decreased significantly from $10 million to $4.3 million year-over-year, impacting overall profitability, attributed to reduced marketable securities holdings. (panabee.com)
Selling, general, and administrative expenses rose by $3.3 million year-over-year, offsetting some of the gross margin improvements, partly due to higher stock-based compensation and one-time leadership transition costs. (panabee.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.
Azenta Financial Performance
Revenues and expenses
Azenta Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Azenta stock?
Azenta (AZTA) has a market cap of $1.5B as of July 15, 2025.
What is the P/E ratio for Azenta stock?
The price to earnings (P/E) ratio for Azenta (AZTA) stock is 0 as of July 15, 2025.
Does Azenta stock pay dividends?
No, Azenta (AZTA) stock does not pay dividends to its shareholders as of July 15, 2025.
When is the next Azenta dividend payment date?
Azenta (AZTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Azenta?
Azenta (AZTA) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.